Immunovant’s (IMVT) Overweight Rating Reiterated at Cantor Fitzgerald
Immunovant (NASDAQ:IMVT – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Cantor Fitzgerald in a note issued to investors on Friday, PriceTargets.com reports. A number of other equities analysts have also recently commented on IMVT. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Immunovant in a research note on […]
More Stories
Head to Head Contrast: SK Growth Opportunities (SKGR) vs. Its Rivals
Earnings & Valuation This table compares SK Growth Opportunities and its competitors revenue, earnings per share and valuation. Gross Revenue...
Fluence Energy, Inc. (NASDAQ:FLNC) Sees Significant Increase in Short Interest
Fluence Energy, Inc. (NASDAQ:FLNC – Get Free Report) was the target of a large increase in short interest in December....
Sable Resources (CVE:SAE) Shares Down 16.7% – Time to Sell?
Shares of Sable Resources Ltd. (CVE:SAE – Get Free Report) fell 16.7% on Saturday . The company traded as low...
De Grey Mining Limited (OTCMKTS:DGMLF) Short Interest Down 30.0% in December
De Grey Mining Limited (OTCMKTS:DGMLF – Get Free Report) was the target of a significant decrease in short interest in...
Short Interest in CHS Inc. (NASDAQ:CHSCO) Decreases By 30.3%
CHS Inc. (NASDAQ:CHSCO – Get Free Report) was the target of a significant decline in short interest in December. As...
Amplify Bloomberg U.S. Treasury Target High Income ETF (TLTP) To Go Ex-Dividend on December 30th
Amplify Bloomberg U.S. Treasury Target High Income ETF (NYSEARCA:TLTP – Get Free Report) announced a dividend on Friday, December 27th,NASDAQ...